Lipocine Inc (LPCN) PT Raised to $3 at H.C. Wainwright Following NDA Resubmission for Tlando Oral TRT
Tweet Send to a Friend
H.C. Wainwright analyst Oren Livnat raised the price target on Lipocine Inc (NASDAQ: LPCN) to $3.00 (from $2.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
